Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2006 2
2007 4
2008 5
2009 12
2010 6
2011 9
2012 4
2013 7
2014 14
2015 13
2016 7
2017 5
2018 9
2019 14
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

115 results
Results by year
Filters applied: . Clear all
Page 1
HEART UK consensus statement on Lipoprotein(a): A call to action.
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: qureshi n. Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Atherosclerosis. 2019. PMID: 31704552 Free article. Review.
Can machine-learning improve cardiovascular risk prediction using routine clinical data?
Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Weng SF, et al. Among authors: qureshi n. PLoS One. 2017 Apr 4;12(4):e0174944. doi: 10.1371/journal.pone.0174944. eCollection 2017. PLoS One. 2017. PMID: 28376093 Free PMC article.
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N, Weng SF, Kai J, Kleijnen J, Qureshi N. Hussein N, et al. Among authors: qureshi n. Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3. Cochrane Database Syst Rev. 2018. PMID: 29537064 Free PMC article. Review.
LDL cholesterol response to statins and future risk of cardiovascular disease.
Akyea RK, Kai J, Qureshi N, Iyen B, Weng SF. Akyea RK, et al. Among authors: qureshi n. Heart. 2019 Aug;105(16):1290-1291. doi: 10.1136/heartjnl-2019-315461. Heart. 2019. PMID: 31350367 No abstract available.
The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort.
Nowakowska M, Zghebi SS, Ashcroft DM, Buchan I, Chew-Graham C, Holt T, Mallen C, Van Marwijk H, Peek N, Perera-Salazar R, Reeves D, Rutter MK, Weng SF, Qureshi N, Mamas MA, Kontopantelis E. Nowakowska M, et al. Among authors: qureshi n. BMC Med. 2019 Jul 25;17(1):145. doi: 10.1186/s12916-019-1373-y. BMC Med. 2019. PMID: 31345214 Free PMC article.
Personalised medicine in general practice: the example of raised cholesterol.
Qureshi N, Humphries SE, Gray H. Qureshi N, et al. Br J Gen Pract. 2018 Feb;68(667):68-69. doi: 10.3399/bjgp18X694481. Br J Gen Pract. 2018. PMID: 29371297 Free PMC article. No abstract available.
Risk of cardiovascular disease outcomes in primary care subjects with familial hypercholesterolaemia: A cohort study.
Iyen B, Qureshi N, Kai J, Akyea RK, Leonardi-Bee J, Roderick P, Humphries SE, Weng S. Iyen B, et al. Among authors: qureshi n. Atherosclerosis. 2019 Aug;287:8-15. doi: 10.1016/j.atherosclerosis.2019.05.017. Epub 2019 May 24. Atherosclerosis. 2019. PMID: 31181417 Free article. Clinical Trial.
Cardiovascular risk assessment and lipid modification: NICE guideline.
Duerden M, O'Flynn N, Qureshi N. Duerden M, et al. Among authors: qureshi n. Br J Gen Pract. 2015 Jul;65(636):378-80. doi: 10.3399/bjgp15X685933. Br J Gen Pract. 2015. PMID: 26120133 Free PMC article. Review. No abstract available.
Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Carroll C, Tappenden P, Rafia R, Hamilton J, Chambers D, Clowes M, Durrington P, Qureshi N, Wierzbicki AS. Carroll C, et al. Among authors: qureshi n. Pharmacoeconomics. 2017 May;35(5):537-547. doi: 10.1007/s40273-017-0492-6. Pharmacoeconomics. 2017. PMID: 28285379 Free article. Review.
115 results
Jump to page